Condition: Attention Deficit Hyperactivity Disorder · Behavior Hyperactive · Behavior Disorders · Sponsor: Nantes University Hospital
The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.
This description comes directly from the study's public registry record.
Clémence CABELGUEN, PH · 33 2 40 84 61 16 · clemence.cabelguen@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| Nantes University Hospital | Nantes, Loire-Atlantique, France | Recruiting |
| CHRU de Brest | Brest, France | Recruiting |
| CHRU de Tours | Tours, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06232226